Page last updated: 2024-11-05

trimethoprim and Anemia, Sickle Cell

trimethoprim has been researched along with Anemia, Sickle Cell in 2 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, RE1
Wilfert, CM1

Reviews

1 review available for trimethoprim and Anemia, Sickle Cell

ArticleYear
Clinical chemistry of folic acid.
    Advances in clinical chemistry, 1986, Volume: 25

    Topics: Absorption; Aged; Alcoholism; Anemia, Sickle Cell; Anticonvulsants; Arthritis, Rheumatoid; Biologica

1986

Other Studies

1 other study available for trimethoprim and Anemia, Sickle Cell

ArticleYear
Trimethoprim-sulfamethoxazole in children: pharmacokinetics and clinical studies.
    The Journal of infectious diseases, 1973, Volume: 128

    Topics: Anemia, Aplastic; Anemia, Sickle Cell; Bacterial Infections; Child; Child, Preschool; Drug Combinati

1973